Temsirolimus in combination with carboplatin and paclitaxel in patients with advanced solid tumors: a NCIC-CTG, phase I, open-label dose-escalation study (IND 179) - Kollmannsberger, C; Hirte, H; Siu, L L (Ann Oncol, 2012)